Market Place
Sourcing Support
FDA Accepts Genentech`s Giredestrant NDA in Early Breast Cancer
02 Jun 2026 //
BUSINESSWIRE
Genentech to Present Obesity Pipeline Data at ADA 2026
01 Jun 2026 //
BUSINESSWIRE
Lupus Alliance & Genentech Fund CAR T Research for Lupus
26 May 2026 //
PRESS RELEASE
Genentech to Present Giredestrant Data at ASCO 2026
19 May 2026 //
BUSINESSWIRE
FDA Clears Roche`s Tecentriq with ctDNA Test for Bladder Cancer
15 May 2026 //
FIERCE PH
FDA Approves Tecentriq for ctDNA-Guided Adjuvant Bladder Cancer
15 May 2026 //
PHARMIWEB
FDA Approves Ocrevus for Pediatric Relapsing-Remitting MS
08 May 2026 //
FIRSTWORD PHARMA
Genentech to Show Full Ophthalmology Portfolio at ARVO 2026
30 Apr 2026 //
BUSINESSWIRE
PSG Report: Costs Exceed Payers` Goals Amid New Specialty Drugs
27 Apr 2026 //
PHARMIWEB
Genentech Launches DME Awareness Campaign With Partners
24 Apr 2026 //
BUSINESSWIRE
Roche’s Enspryng cuts relapse risk by 68% in Neuroinflammatory
22 Apr 2026 //
PRESS RELEASE
FDA Accepts Genentech`s Gazyva Application For Lupus Treatment
21 Apr 2026 //
PHARMIWEB
Genentech`s Enspryng Cuts MOGAD Relapses by 68%
21 Apr 2026 //
PHARMIWEB
Genentech shifts Hemlibra marketing focus to patient stories
20 Apr 2026 //
FIERCE PHARMA
AACR: Genentech veteran engineers ‘smart’ cancer drug startup
19 Apr 2026 //
FIERCE BIOTECH
ATUM Welcomes Gavin Barnard, Ph.D., As Chief Scientific Officer
16 Apr 2026 //
GLOBENEWSWIRE
Novocure Touts Positive Data In Metastatic Pancreatic Cancer
27 Mar 2026 //
FIERCE BIOTECH
Genentech Walks The Walk In Lupus As Sponsor Of Annual Event
26 Mar 2026 //
FIERCE PHARMA
Genentech Drug Fails Rare Disease Trial, Raises Obesity Risk
20 Mar 2026 //
FIERCE BIOTECH
Roche Halts SMA Drug, Boosting Rivals` Prospects
20 Mar 2026 //
BIOSPACE
Genentech Shreds RIPK1 Inhibitor After Ph. 2 Failure
19 Mar 2026 //
FIERCE BIOTECH
Genentech CEO Says Aiming for Tolerable, Affordable Obesity drugs
17 Mar 2026 //
REUTERS
Genentech`s Gazyva Reduces Lupus Activity In Phase III Data
06 Mar 2026 //
PHARMIWEB
Genentech Announces Positive Phase II Results for Petrelintide
05 Mar 2026 //
PHARMIWEB
Genentech’s Fenebrutinib Shows Phase 3 Success in MS Trials
02 Mar 2026 //
PHARMIWEB
FDA Approves Venclexta, Acalabrutinib For Untreated CLL Leukemia
23 Feb 2026 //
PRESS RELEASE
Roche Announces Positive Phase III Results For Gazyva/Gazyvaro
17 Feb 2026 //
GLOBENEWSWIRE
Genprex To Receive Patent In Australia For Reqorsa Gene Therapy
10 Feb 2026 //
PR NEWSWIRE
Delayed Notice Reveals 141 More Layoffs From Genentech In 2025
09 Feb 2026 //
BIOSPACE
Genentech`s Fenebrutinib Reduces Disability Progression
07 Feb 2026 //
PHARMIWEB
Genentech Cut At Least 489 Jobs Last Year, New Filing Reveals
06 Feb 2026 //
FIERCE PHARMA
Roche Continues RNA Return With $1.7B Deal For Sanegene Drug
03 Feb 2026 //
FIERCE BIOTECH
Roche Scales Genentech`s NC Obesity Drug Site To $2B
21 Jan 2026 //
FIERCE PHARMA
Biotech Showcase Facilitates Investor, Pharma, And Media Access
08 Jan 2026 //
PHARMIWEB
Ollin Eyes Phase 3 After Topping Vabysmo In Early-Stage Trial
08 Jan 2026 //
FIERCE BIOTECH
Roche Commits $100M To Keep Its GLP-1 Structure Sound
06 Jan 2026 //
FIERCE BIOTECH
FDA Approves Roche`s Lunsumio VELO For Subcutaneous Use
22 Dec 2025 //
GLOBENEWSWIRE
Genentech Announces Agreement With U.S. Government
20 Dec 2025 //
BUSINESSWIRE
Caris, Genentech Collaborate on Novel Cancer Targets
16 Dec 2025 //
PR NEWSWIRE
Redhill Bio Opaganib Shows Promise In Venetoclax-Resistant Cells
15 Dec 2025 //
PR NEWSWIRE
Genentech`s Giredestrant Cuts Er-Positive Breast Cancer
10 Dec 2025 //
BUSINESSWIRE
Genentech Uncovers `Hidden Gems` In Latest #Msvisibility Drive
09 Dec 2025 //
FIERCE PHARMA
Genentech Reveals Lunsumio Data In Early Lymphoma Treatment Lines
08 Dec 2025 //
BUSINESSWIRE
Genentech`s Giredestrant Shows Superior iDFS in Breast Cancer
18 Nov 2025 //
BUSINESSWIRE
Roche`s Experimental MS Drug Hits Main Goal in One of Two Trial
09 Nov 2025 //
BUSINESSWIRE
Positive Phase III Data for Genentech’s Gazyva for Lupus
03 Nov 2025 //
BUSINESSWIRE
Genentech To Unveil Hematology Portfolio Data at ASH 2025
03 Nov 2025 //
BUSINESSWIRE
Genentech Lets 118 Staffers Go In Another HQ Layoff Round
29 Oct 2025 //
FIERCE BIOTECH
Ventus Pharma Collaborates With Genentech On Small-Molecule
21 Oct 2025 //
BUSINESSWIRE
Genentech`s Tecentriq Demonstrates Major Survival Gains
20 Oct 2025 //
PHARMIWEB
Lupus Research Alliance Cheers FDA Approval Of Gazyva For Lupus
20 Oct 2025 //
PR NEWSWIRE
Genentech Presents Ph3 Data for Vamikibart in UME
17 Oct 2025 //
PHARMIWEB
Genentech Expands Xofluza Access For Flu Season
16 Oct 2025 //
BUSINESSWIRE
Genentech`s 1st DTC Program Centers On Discounted Xofluza
16 Oct 2025 //
FIERCE PHARMA
Genentech Showcases Science And Cancer Care Advances At ESMO 2025
14 Oct 2025 //
BUSINESSWIRE
Roche Showcases Science And Cancer Care Advances At ESMO 2025
13 Oct 2025 //
GLOBENEWSWIRE
Genentech Awarded $124M In Cabilly Patent Dispute With Biogen
06 Oct 2025 //
FIERCE PHARMA
Genentech Unveils Ocrevus, Fenebrutinib Data At ECTRIMS 2025
24 Sep 2025 //
BUSINESSWIRE
Roche Prsent Ocrevus And Fenebrutinib Data at ECTRIMS 2025
24 Sep 2025 //
GLOBENEWSWIRE
Roche Reports Phase 3 Breast Cancer Victory for Oral Serd
24 Sep 2025 //
FIERCE BIOTECH
